Prognostic Stage 2 Breast Cancer AJCC v8 Completed Phase 1 Trials for Doxorubicin (DB00997)

Also known as: Prognostic Stage II Breast Cancer AJCC v8

IndicationStatusPhase
DBCOND0140767 (Prognostic Stage 2 Breast Cancer AJCC v8)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04081389Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast CancerTreatment